脓毒症新型免疫调节疗法的关键见解：在局限性中评估前景。
Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations.
作者信息
Angadi Varun M, Kambagiri Pratyusha, Jindal Atul
机构信息
Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, India.
出版信息
Indian J Crit Care Med. 2025 Jan;29(1):90. doi: 10.5005/jp-journals-10071-24847. Epub 2024 Dec 30.
Abstract
Angadi VM, Kambagiri P, Jindal A. Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations. Indian J Crit Care Med 2025;29(1):90.
摘要
安加迪·VM、坎巴吉里·P、金达尔·A。脓毒症新型免疫调节疗法的关键见解：在局限性中评估前景。《印度重症监护医学杂志》2025年；29(1):90。
相似文献
1
Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations.脓毒症新型免疫调节疗法的关键见解：在局限性中评估前景。
Indian J Crit Care Med. 2025 Jan;29(1):90. doi: 10.5005/jp-journals-10071-24847. Epub 2024 Dec 30.
2
To C or not to C? Designing a Pragmatic Trial to Deploy a Novel Immunomodulatory Therapy to Fight Organ Dysfunction in Sepsis.是选择C还是不选C？设计一项务实试验以应用新型免疫调节疗法对抗脓毒症中的器官功能障碍。
Indian J Crit Care Med. 2024 Mar;28(3):311. doi: 10.5005/jp-journals-10071-24636.
3
Author Response: Insights into Immunomodulatory Therapy for Sepsis.作者回应：脓毒症免疫调节治疗的见解
Indian J Crit Care Med. 2025 Jan;29(1):91. doi: 10.5005/jp-journals-10071-24874. Epub 2024 Dec 30.
4
Polymyxin B Hemoperfusion in Sepsis: A Possible Silver Lining to the Dark Clouds?脓毒症中多黏菌素B血液灌流：黑暗中的一线曙光？
Indian J Crit Care Med. 2024 Oct;28(10):903-905. doi: 10.5005/jp-journals-10071-24816. Epub 2024 Sep 30.
5
Methylene Blue in Septic Shock-A Novel Weapon in Our Arsenal: Are Utility Studies Highlighting its Futility?亚甲蓝在感染性休克中的应用——我们武器库中的一种新型武器：效用研究是否凸显了其无用性？
Indian J Crit Care Med. 2024 Jan;28(1):89. doi: 10.5005/jp-journals-10071-24589.
6
Efficacy of Polymyxin B Hemoperfusion for Treatment of Sepsis.多黏菌素B血液灌流治疗脓毒症的疗效
Indian J Crit Care Med. 2024 Oct;28(10):930-934. doi: 10.5005/jp-journals-10071-24805. Epub 2024 Sep 30.
7
Deciphering Oxygenation Metrics in ARDS: A Deep Dive into the OXIVA-CARDS Study.解读急性呼吸窘迫综合征中的氧合指标：深入探讨OXIVA-CARDS研究
Indian J Crit Care Med. 2025 Mar;29(3):282. doi: 10.5005/jp-journals-10071-24846.
8
Impact of polymyxin B hemoperfusion in the treatment of patients with sepsis and septic shock: a meta-analysis of randomized controlled trials.多粘菌素B血液灌流对脓毒症和脓毒性休克患者治疗的影响：一项随机对照试验的荟萃分析
Ann Transl Med. 2018 Jun;6(11):206. doi: 10.21037/atm.2018.05.41.
9
Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.早期应用多粘菌素B血液灌流治疗腹部感染性休克：EUPHAS随机对照试验
JAMA. 2009 Jun 17;301(23):2445-52. doi: 10.1001/jama.2009.856.
10
COVID-19 and T Cells: Do T Cells Really Matter?新型冠状病毒肺炎与T细胞：T细胞真的重要吗？
Indian J Crit Care Med. 2023 Jan;27(1):75. doi: 10.5005/jp-journals-10071-24385.
本文引用的文献
1
Efficacy of Polymyxin B Hemoperfusion for Treatment of Sepsis.多黏菌素B血液灌流治疗脓毒症的疗效
Indian J Crit Care Med. 2024 Oct;28(10):930-934. doi: 10.5005/jp-journals-10071-24805. Epub 2024 Sep 30.
2
Recent Advances in Immunomodulatory Therapy in Sepsis: A Comprehensive Review.脓毒症免疫调节治疗的最新进展：全面综述
Cureus. 2024 Mar 31;16(3):e57309. doi: 10.7759/cureus.57309. eCollection 2024 Mar.
3
Immunomodulatory drugs in sepsis: a systematic review and meta-analysis.脓毒症的免疫调节药物：系统评价和荟萃分析。
Anaesthesia. 2024 Aug;79(8):869-879. doi: 10.1111/anae.16263. Epub 2024 Mar 24.
4
Mechanisms and modulation of sepsis-induced immune dysfunction in children.脓毒症引起的儿童免疫功能障碍的机制与调节。
Pediatr Res. 2022 Jan;91(2):447-453. doi: 10.1038/s41390-021-01879-8. Epub 2021 Dec 24.
5
Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis.聚明胶肽固定化血液灌流治疗脓毒症和感染性休克的疗效：系统评价和荟萃分析。
J Crit Care. 2021 Jun;63:187-195. doi: 10.1016/j.jcrc.2020.09.007. Epub 2020 Sep 18.
Zotero 插件